Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
TOKYO, JAPAN: Mitsubishi Tanabe Pharma, subsidiary of Mitsubishi Chemical Holdings, completed all the procedures for the acquisition of Medicago Inc, a pharmaceutical company based in Canada. The acquisition was announced on 12 July 2013. As a result of the acquisition, Medicago has become a subsidiary of Mitsubishi Tanabe Pharma. Medicago will be operated as a joint venture owned 60 per cent by Mitsubishi Tanabe Pharma and 40 per cent by Phillip Morris Investments BV.
© Worldofchemicals News
Login
CALIFORNIA, US: “Opposite charges attract and like charges repel,” is a universal scientific truth. A research team led by Richard Saykall ...
IRVING, US: Fluor Corporation’s ICA Fluor industrial engineering-construction joint venture with Empresas ICA, SAB de CV was awarded a new contr ...
SHANGHAI, CHINA: Henkel has inaugurated the world’s largest adhesives factory in Shanghai, China. With this new production facility, Henkel will ...
DES PLAINES, US: UOP LLC, a Honeywell company, has been selected to produce key ingredients for fuels and synthetic rubber in China. China’s Pan ...
BAGSVAERD, DENMARK: Novozymes has entered into a collaboration agreement with Brazil’s largest sugarcane crusher, Raizen Energia S/A. Novozymes ...
LUDWIGSHAFEN, GERMANY: BASF opened a new production plant for concrete admixtures in Kazan, Russia. Along with the facility inaugurated in Podolsk nea ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder